LJPC

La Jolla Pharmaceutical (LJPC)

La Jolla Pharmaceutical Company

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:LJPC

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2023/02/15	00 : 07	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/09/01	21 : 39	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/30	01 : 31	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/30	01 : 10	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/24	06 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/24	06 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/24	06 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/24	06 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/24	06 : 01	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/22	22 : 32	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/22	22 : 22	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/22	22 : 20	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/22	22 : 09	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/22	21 : 55	Business Wire	Innoviva Completes Acquisition of La Jolla Pharmaceutical	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/15	21 : 14	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/08/15	21 : 04	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/07/25	21 : 40	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/07/25	21 : 35	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/07/12	19 : 10	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/07/12	19 : 01	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/07/12	04 : 47	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/07/11	20 : 36	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/07/11	20 : 32	Business Wire	Innoviva to Acquire La Jolla Pharmaceutical Company	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/07/06	06 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/05/18	06 : 08	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/05/17	05 : 18	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/05/17	05 : 15	Business Wire	La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/04/19	07 : 33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/04/19	07 : 31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:LJPC	La Jolla Pharmaceutical Company
2022/04/05	06 : 40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:LJPC	La Jolla Pharmaceutical Company